Do Red Blood Cells Grow? How RBCs Form and Mature

Mature red blood cells do not grow, and they cannot divide or reproduce. Once a red blood cell reaches full maturity, it has already shed its nucleus and most of its internal machinery, leaving it with no way to copy DNA, run cell division, or even repair itself. What the body does instead is constantly manufacture brand-new red blood cells in the bone marrow to replace the ones that wear out after about 120 days. So when people ask whether red blood cells grow, the honest answer is: the precursor cells that become RBCs absolutely go through growth and division, but the finished product does not.

What red blood cells actually are (and why "growing" doesn't apply)

A mature red blood cell is basically a stripped-down delivery vehicle. It has a distinctive biconcave disc shape, it carries hemoglobin, and it is built for one job: shuttling oxygen from your lungs to your tissues and hauling carbon dioxide back. To do that job efficiently, the cell goes through a radical transformation during development. It ejects its nucleus, dismantles its mitochondria, gets rid of its endoplasmic reticulum and Golgi apparatus, and sheds essentially every organelle that nucleated cells rely on to grow, divide, and maintain themselves.

That stripping-down is not a flaw. It frees up more internal space for hemoglobin and makes the cell flexible enough to squeeze through the narrowest capillaries. But it means the mature RBC is, in a meaningful biological sense, a cell that has voluntarily dismantled its own growth machinery. Without a nucleus there is no DNA. Without DNA there is no RNA. Without RNA there is no protein synthesis and no pathway to mitosis. The cell literally cannot grow even if the conditions were ideal for it.

This puts RBCs in a very different category from most cells you might think about. Skin cells divide and renew. Liver cells can regenerate. Even muscle cells, which are largely post-mitotic, retain their nuclei. Red blood cells are one of the few cell types that genuinely have no internal toolkit left for any kind of growth after maturity.

How new red blood cells are made: erythropoiesis from start to finish

The process of making red blood cells is called erythropoiesis, and it happens almost entirely in the red bone marrow. Think of the marrow as a continuous manufacturing line that runs every single day of your life. At the start of the line are hematopoietic stem cells, which are multipotent cells that can commit to becoming any blood cell type. When they commit to the red blood cell path, they move through a series of increasingly specialized stages.

The hormone that kicks it all off: erythropoietin

The signal driving this whole process is erythropoietin, almost always called EPO. When your blood oxygen drops, specialized fibroblast-like cells in the kidney detect the low oxygen levels and ramp up EPO production. The trigger is a protein called hypoxia-inducible factor 2 (HIF-2), which acts as a transcriptional switch: low oxygen activates HIF-2, HIF-2 cranks up EPO gene expression, and EPO floods the bloodstream and reaches the bone marrow. There, it tells erythroid progenitor cells to proliferate faster and mature more quickly. When oxygen levels recover, the signal dies down. It is a clean feedback loop that matches RBC production to the body's actual oxygen demand.

Cell division during development: the mitotic phase

Here is where the growth and division that people might associate with RBCs actually happens. The earliest recognizable erythroid cell, called the pro-erythroblast, undergoes roughly four to five rounds of mitosis. Each division produces daughter cells that are progressively smaller and more specialized: basophilic erythroblasts, then polychromatophilic erythroblasts, and finally orthochromatic erythroblasts. By the orthochromatic stage, the cell cycle has shut down completely. The cell arrests, its chromatin compacts, and it prepares for the final step: ejecting its nucleus.

That ejection event, called enucleation, produces two structures. One is the pyrenocyte, which is just the expelled nucleus wrapped in a thin membrane. The other is the reticulocyte, an anucleate young cell that still contains traces of RNA and a few residual organelles. The reticulocyte enters circulation and within about one day finishes maturing into the fully stripped-down red blood cell. It loses its remaining RNA and becomes the smooth, biconcave RBC you see in textbook diagrams. So any cell division associated with RBCs happens before enucleation, deep in the marrow, not in circulation.

How long RBCs last and what happens when they wear out

A mature red blood cell circulates for about 120 days. Over that time it takes a beating, literally. It gets squeezed through capillaries smaller than its own diameter, it cycles through changes in pH and oxygen pressure thousands of times, and its membrane gradually stiffens and oxidizes. Without a nucleus or ribosomes, it cannot make new proteins to repair damage. The wear accumulates.

Around the 120-day mark, aging RBCs start displaying molecular signals on their surface, including changes to a membrane protein called Band 3 and the attachment of complement proteins. These act as "eat me" flags that macrophages in the spleen, liver, and bone marrow recognize. The macrophages engulf the old cells, break them down, and recycle the iron and other components. This clearance is not a failure of growth; it is a programmed, orderly retirement system.

The key point is that nothing about this lifespan involves the RBC getting bigger, stronger, or more capable as it ages. There is no growth phase in maturity. The cell is effectively static from the moment it finishes maturing until the moment it is cleared.

More RBCs vs. bigger RBCs: it's always about production rate

When the body needs more oxygen-carrying capacity, it does not grow existing red blood cells larger. It makes more of them. Healthy adults renew roughly 170 billion red blood cells every single day. That staggering number reflects a steady-state balance: about the same number of new reticulocytes are released from the marrow as old RBCs are cleared by macrophages.

You can track this production rate by measuring reticulocytes. Normally, reticulocytes make up about 1-2% of circulating red blood cells. If the percentage jumps, it means the marrow is accelerating production, usually in response to anemia, blood loss, or hemolysis. If the reticulocyte count stays low when RBC numbers are falling, it tells clinicians the marrow is not responding adequately, which points to conditions like iron deficiency, B12 deficiency, or bone marrow suppression. Importantly, the increased reticulocyte count appears about 3 to 4 days after an acute drop in RBC mass, reflecting the time it takes for the marrow to ramp up and release new cells, not for existing ones to change.

Anemia, in this light, is almost never a story about RBCs failing to grow after maturity. It is a story about production not keeping pace with destruction or loss. The treatment logic follows from that: fix the production problem (supply iron, B12, or folate; treat the underlying marrow issue; use EPO-stimulating agents in certain kidney disease cases) and the new RBC supply recovers.

Growing RBCs in a lab: what that actually means

Researchers and biotech companies do talk about "growing" red blood cells, which can sound confusing given everything above. What they mean is culturing the precursor cells, not the mature RBCs themselves. The goal is to start with hematopoietic stem cells or induced pluripotent stem cells (iPSCs) and push them through the same erythropoiesis process in a dish, ultimately producing enucleated red blood cells that could theoretically be used for transfusions.

One established approach uses a two-step liquid culture method. In the first phase, progenitor cells expand without EPO. In the second phase, EPO is added to drive the cells through differentiation toward orthochromatic normoblasts, followed by enucleation. Researchers have also developed systems that let them watch nascent reticulocytes finish maturing in culture, giving a window into that final transition from reticulocyte to fully mature RBC.

But this field still has real bottlenecks. Getting cells to complete enucleation efficiently, achieving the proper biconcave disc shape, avoiding immature RBC characteristics, and scaling production to clinically useful quantities are all ongoing challenges as of 2026. The point is that even in the lab, scientists are not making mature RBCs grow or divide. They are recapitulating the natural development process, just outside the body.

Why mature RBCs can't just keep dividing: the physics and biology of limits

It is worth stepping back and asking why terminal differentiation exists at all. Why would a cell permanently shut off its ability to divide? The answer involves both function and safety.

On the functional side, the same organelles that enable division take up space and resources that, in an RBC, are better spent on hemoglobin. A cell that kept its nucleus would be less efficient at its core job. On the safety side, cells that divide without restraint are the definition of cancer. Terminally differentiated cells like mature RBCs, neurons, and cardiac muscle cells exit the cell cycle permanently, which removes them from the population of cells that could accumulate mutations and proliferate uncontrollably. The cell-cycle machinery itself is effectively dismantled in these states, meaning growth signals from outside the cell have nothing to act on even if they arrive.

For RBCs specifically, the transcriptional programs driven by factors like GATA-1 and related epigenetic regulators orchestrate the shift from proliferation to maturation. Once those programs commit the cell to terminal differentiation, the process is irreversible. No external signal, no matter how strong, can push a mature red blood cell back into division. This is a fundamentally different situation from cells that simply happen to be resting and could in principle re-enter the cycle under the right conditions.

This kind of hard limit on cell division is a theme that runs across biology. If you are curious how other cell types navigate the tension between growth and restraint, it is worth comparing RBCs to skin cells or animal cells more broadly, where the growth rules are quite different because the nucleus is still present and the cell cycle is still available.

The bottom line: what "growing" means for red blood cells

Red blood cells grow and divide only during their development in the bone marrow, while they still have a nucleus. In the case of red blood cells, that growth happens during development in the bone marrow, where cells divide and mature over days how fast do cells grow. Once enucleation happens, all growth stops permanently. The body compensates by running erythropoiesis continuously, replacing roughly 170 billion cells daily. If your RBC count is low, the answer is always found upstream in production, never in trying to make mature RBCs grow. That distinction matters whether you are studying for an exam, trying to understand a blood test result, or just curious about how one of your body's most abundant cells actually works. If you meant “growth” in the sense of resizing or expanding text within an Excel cell, you can adjust font size, enable wrap text, and format row height to fit the content make cells grow with text in excel.